The US dollar held steady at 98 on Tuesday, remaining near its lowest level since early October, as investors awaited the Federal Reserve’s December meeting minutes for further clues on the path of interest rates. Markets are currently pricing in two more rate cuts in 2026, although Fed officials were divided over their next move, with most foreseeing only one reduction. Meanwhile, data on Monday showed that pending home sales jumped 3.3% in November, beating forecasts of a 1% increase, signaling improving housing demand. However, the Dallas Fed manufacturing survey indicated weaker business conditions in December. So far this year, the dollar has declined 9.6%, marking its sharpest fall since 2017. The greenback’s weakness reflects a combination of factors, including expectations of Fed rate cuts, narrowing interest rate differentials with other major currencies, President Trump’s chaotic tariff policies, and concerns over fiscal deficits and the Fed’s independence.
Read Next
Markets
13 hours ago
Three Markets to Watch Next Week
Markets
13 hours ago
BlackRock – The Earnings And What it Reflects
Markets
14 hours ago
Bank And Fund Earnings Support Valuations
Markets
14 hours ago
Can Midcap Stocks Outperform The Global Rally
Markets
14 hours ago
Iran Tensions Underpin Crude Oil Prices
Markets
1 day ago
Sensex Finishes in the Green
Markets
1 day ago
Chart of The Day – USDJPY
13 hours ago
Three Markets to Watch Next Week
13 hours ago
BlackRock – The Earnings And What it Reflects
14 hours ago
Bank And Fund Earnings Support Valuations
14 hours ago
Can Midcap Stocks Outperform The Global Rally
14 hours ago
AI Powered Software Stock – U.S. Tech Stocks Tumble, Whats Next?
14 hours ago
Iran Tensions Underpin Crude Oil Prices
1 day ago
Sensex Finishes in the Green
1 day ago
Cocoa Bears? – Weak E.U. Grindings And Solid African Harvests Drive Prices
1 day ago
Chart of The Day – USDJPY
1 day ago
Palladium Retreats on Tariff Delay and Iran Tensions
Related Articles
Check Also
Close
-
FTSE 100 Trades Higher Led by Precious Miners, AstraZenecaOctober 13, 2025





